Where I see patients (1)
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis.
Critical care (London, England)
Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial.
Critical care medicine
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection.
Open forum infectious diseases
- Refer a patient
- (415) 353-2626